Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0251 Transporter Info | ||||
| Gene Name | SLC2A1 | ||||
| Transporter Name | Glucose transporter type 1, erythrocyte/brain | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Caffeine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 2519 | ||||
| Docking Score | -7.102 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C8H10N4O2 | ||||
| Molecular Weight | 194.19 | ||||
| Canonical SMILES |
CN1C=NC2=C1C(=O)N(C(=O)N2C)C
|
||||
| InChI |
InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
|
||||
| InChIKey | RYYVLZVUVIJVGH-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.1 | Rotatable Bond Count | 0 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | ||
| Xenobiotic Name | Dapagliflozin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 9887712 | ||||
| Docking Score | -6.906 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H25ClO6 | ||||
| Molecular Weight | 408.9 | ||||
| Canonical SMILES |
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl
|
||||
| InChI |
InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
|
||||
| InChIKey | JVHXJTBJCFBINQ-ADAARDCZSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.3 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.